Optimization of Field Design in the Treatment of Rectal Cancer with Intensity Modulated Proton Beam Radiation Therapy: How Many Fields Are Needed to Account for Rectal Distension U...

by Jacob S. Parzen, MD, Weili Zheng, PhD, Xiaoqiang Li, PhD, Xuanfeng Ding, PhD, Peyman Kabolizadeh, MD, PhD
Published 2021-09-01

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group

by Jacob S. Parzen, William Hartsell, John Chang, Smith Apisarnthanarax, Jason Molitoris, Michael Durci, Henry Tsai, James Urbanic, Jonathan Ashman, Carlos Vargas, Craig Stevens, Peyman Kabolizadeh
Published 2020-11-01

Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial

by Jacob S. Parzen, MD, Michael D. Chuong, MD, John Chang, MD, Lane Rosen, MD, James Urbanic, MD, William Hartsell, MD, Henry Tsai, MD, Christopher Sinesi, MD, Jing Zeng, MD, Mark Mishra, MD, Carlos Vargas, MD, Craig Stevens, MD, PhD, Peyman Kabolizadeh, MD, PhD
Published 2021-09-01